Literature DB >> 11781268

Clinical aspects and pathophysiology of inflammatory bowel disease.

Barbara A Hendrickson1, Ranjana Gokhale, Judy H Cho.   

Abstract

The chronic inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, are recognized as important causes of gastrointestinal disease in children and adults. In this review we delineate the clinical manifestations and diagnostic features of IBD. In addition, we summarize important recent advances in our understanding of the immune mediators of intestinal inflammation. This information has led to new therapeutic approaches in IBD. Further, we discuss the considerable data that point to the significance of genetic factors in the development of IBD and the genetic loci which have been implicated through genome-wide searches. The commensal bacterial flora also appears to be a critical element, particularly in regards to Crohn's disease, although the precise role of the bacteria in the disease manifestations remains unclear. Current investigations promise to yield fresh insights in these areas.

Entities:  

Mesh:

Year:  2002        PMID: 11781268      PMCID: PMC118061          DOI: 10.1128/CMR.15.1.79-94.2002

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  136 in total

1.  Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease.

Authors:  F M Ruemmele; S R Targan; G Levy; M Dubinsky; J Braun; E G Seidman
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

2.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

3.  Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12.

Authors:  J Satsangi; M Parkes; E Louis; L Hashimoto; N Kato; K Welsh; J D Terwilliger; G M Lathrop; J I Bell; D P Jewell
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

4.  Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain.

Authors:  S Matsumoto; Y Okabe; H Setoyama; K Takayama; J Ohtsuka; H Funahashi; A Imaoka; Y Okada; Y Umesaki
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

5.  Polymorphism of the 5'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese.

Authors:  T Higuchi; N Seki; S Kamizono; A Yamada; A Kimura; H Kato; K Itoh
Journal:  Tissue Antigens       Date:  1998-06

6.  Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1.

Authors:  J H Cho; D L Nicolae; L H Gold; C T Fields; M C LaBuda; P M Rohal; M R Pickles; L Qin; Y Fu; J S Mann; B S Kirschner; E W Jabs; J Weber; S B Hanauer; T M Bayless; S R Brant
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

7.  Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease.

Authors:  B S Kirschner
Journal:  Gastroenterology       Date:  1998-10       Impact factor: 22.682

8.  Inflammatory bowel disease in African-American children living in Georgia.

Authors:  S O Ogunbi; J A Ransom; K Sullivan; B T Schoen; B D Gold
Journal:  J Pediatr       Date:  1998-07       Impact factor: 4.406

Review 9.  Review article: bone and joint diseases in inflammatory bowel disease.

Authors:  M De Vos; F De Keyser; H Mielants; C Cuvelier; E Veys
Journal:  Aliment Pharmacol Ther       Date:  1998-05       Impact factor: 8.171

10.  Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4.

Authors:  M Boirivant; I J Fuss; A Chu; W Strober
Journal:  J Exp Med       Date:  1998-11-16       Impact factor: 14.307

View more
  146 in total

1.  Emu oil increases colonic crypt depth in a rat model of ulcerative colitis.

Authors:  Suzanne M Abimosleh; Ruth J Lindsay; Ross N Butler; Adrian G Cummins; Gordon S Howarth
Journal:  Dig Dis Sci       Date:  2011-12-07       Impact factor: 3.199

Review 2.  Future therapies for inflammatory bowel disease.

Authors:  Stephen J Bickston; Lawrence W Comerford; Fabio Cominelli
Journal:  Curr Gastroenterol Rep       Date:  2003-12

3.  A Verbal Fluency Task-Based Brain Activation fMRI Study in Patients with Crohn's Disease in Remission.

Authors:  Veena A Nair; Keith Dodd; Shruti Rajan; Anu Santhanubosu; Poonam Beniwal-Patel; Sumona Saha; Vivek Prabhakaran
Journal:  J Neuroimaging       Date:  2019-05-27       Impact factor: 2.486

Review 4.  Radical induction theory of ulcerative colitis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

5.  Culture-independent analyses of temporal variation of the dominant fecal microbiota and targeted bacterial subgroups in Crohn's disease.

Authors:  Pauline D Scanlan; Fergus Shanahan; Caitlin O'Mahony; Julian R Marchesi
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

6.  Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?

Authors:  Christelle Basset; John Holton; Alexandra Bazeos; Dino Vaira; Stuart Bloom
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

7.  Preventive effect of a pectic polysaccharide of the common cranberry Vaccinium oxycoccos L. on acetic acid-induced colitis in mice.

Authors:  Sergey V Popov; Pavel A Markov; Ida-R Nikitina; Sergey Petrishev; Vasily Smirnov; Yury S Ovodov
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Development of fatal colitis in FVB mice infected with Citrobacter rodentium.

Authors:  Diana Borenshtein; Prashant R Nambiar; Elizabeth B Groff; James G Fox; David B Schauer
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

Review 9.  Functional role of eosinophils in gastrointestinal inflammation.

Authors:  Simon P Hogan
Journal:  Immunol Allergy Clin North Am       Date:  2009-02       Impact factor: 3.479

10.  Angiopoietin-2 in experimental colitis.

Authors:  Vijay C Ganta; Walter Cromer; Ginny L Mills; James Traylor; Merilyn Jennings; Sarah Daley; Benjamin Clark; J Michael Mathis; Michael Bernas; Moheb Boktor; Paul Jordan; Marlys Witte; J Steven Alexander
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.